(Q68345009)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2115817%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Phase I/II study of recombinant interferon alpha and gamma in advanced progressive renal-cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2115817%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

author name string

P H de Mulder

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2115817%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

F M Debruyne

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2115817%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

M P Franssen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2115817%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

A D Geboers

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2115817%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

S Strijk

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2115817%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

A G Reintjes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2115817%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

W H Doesburg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2115817%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

O Damsma

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2115817%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2115817%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

23 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2115817%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2115817%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2115817%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

321-324

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2115817%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01740941

23 September 2019

exact match

0 references

cites work

Interferon therapy in cancer: from imaginon to interferon.

1 reference

12 December 2020

Recombinant interferon-gamma increases HLA-DR synthesis and expression

1 reference

12 December 2020

Interferon treatment of renal cell carcinoma. Current status and future prospects

1 reference

12 December 2020

Recombinant interferon gamma in the treatment of metastatic renal cell carcinoma. Results of a phase II trial

1 reference

12 December 2020

A prospective randomized trial of alpha 2B-interferon/gamma-interferon or the combination in advanced metastatic renal cell carcinoma

1 reference

12 December 2020

Synergistic antiproliferative effect of recombinant alpha-interferons with recombinant gamma-interferon

1 reference

12 December 2020

The diagnosis and treatment of renal cell carcinoma

1 reference

12 December 2020

Phase II studies of recombinant human interferon gamma in metastatic renal cell carcinoma

1 reference

12 December 2020

Recombinant interferon alpha and gamma in combination as treatment for metastatic renal cell carcinoma

1 reference

12 December 2020

Phase I/II trial of human recombinant interferon gamma in renal cell carcinoma

1 reference

12 December 2020

Phase I/II study of recombinant interferon gamma in advanced renal cell carcinoma

1 reference

12 December 2020

The natural history of metastatic renal cell carcinoma: a computer analysis

1 reference

12 December 2020

Tumoricidal activity of human monocytes: evidence for cytolytic function distinct from that of NK cells

1 reference

12 December 2020

Alpha and gamma interferon in the treatment of advanced renal cell carcinoma

1 reference

12 December 2020

Renal cell carcinoma: antitumor effects of leukocyte interferon

1 reference

12 December 2020

Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations

1 reference

12 December 2020

In vitro antiproliferative efficacy of interferon-alpha, -gamma and tumor necrosis factor on two human renal tumor xenografts

1 reference

12 December 2020

Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy

1 reference

12 December 2020

Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon

1 reference

12 December 2020

Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons

1 reference

12 December 2020

Activation or suppression of the tumoricidal properties of monocytes from cancer patients following treatment with human recombinant gamma-interferon.

1 reference

12 December 2020

The determination of an immunologically active dose of interferon-gamma in patients with melanoma

1 reference

12 December 2020

Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01740941

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2115817%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference